Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Tru St Partnership, L.P.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Integra LifeSciences (IART) PT Raised to $75 at Truist Securities
February 18, 2021 4:21 PM ESTTruist Securities analyst Kaila Krum raised the price target on Integra LifeSciences (NASDAQ: IART) to $75.00 (from $70.00) while maintaining a Buy rating.
The analyst comments "Integra announced Q4 2020 results, with revenue of $389 million coming in at the high end of its preliminary range that... More



